Cardiac diseases in AIDS pathophysiology: Difference between revisions
Created page with "__NOTOC__ {{Cardiac diseases in AIDS}} {{CMG}}; {{AE}} {{RT}} ==Pathophysiology== ==References== {{Reflist|2}} Category:Cardiology Category:Infectious disease {{Wi..." |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Cardiac diseases in AIDS}} | {{Cardiac diseases in AIDS}} | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{RT}} | ||
==Overview== | |||
Many observational studies have shown that HIV-infected patients are at an increased risk for developing a variety of cardiac diseases. With the introduction of HAART, longevity of HIV-infected patients increased, in turn leading to increased prevalence of cardiac and allied diseases. Inflammation and immune regulation leading to atherogenesis, endothelial dysfunction and coagulation abnormalities have been proposed as the major factors in the pathogenesis of cardiovascular diseases in AIDS. Compared to age-matched uninfected controls, HIV-infected patients have a higher risk of myocardial infarction and cardiovascular death, even with effective anti-retroviral therapy. | |||
==Pathophysiology== | ==Pathophysiology== | ||
Revision as of 21:39, 28 June 2013
|
Cardiac diseases in AIDS Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac diseases in AIDS pathophysiology On the Web |
|
American Roentgen Ray Society Images of Cardiac diseases in AIDS pathophysiology |
|
Risk calculators and risk factors for Cardiac diseases in AIDS pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Overview
Many observational studies have shown that HIV-infected patients are at an increased risk for developing a variety of cardiac diseases. With the introduction of HAART, longevity of HIV-infected patients increased, in turn leading to increased prevalence of cardiac and allied diseases. Inflammation and immune regulation leading to atherogenesis, endothelial dysfunction and coagulation abnormalities have been proposed as the major factors in the pathogenesis of cardiovascular diseases in AIDS. Compared to age-matched uninfected controls, HIV-infected patients have a higher risk of myocardial infarction and cardiovascular death, even with effective anti-retroviral therapy.